Ran GTPase-Activating Protein 1 Is a Therapeutic Target in Diffuse Large B-Cell Lymphoma

Lymphoma-specific biomarkers contribute to therapeutic strategies and the study of tumorigenesis. Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma. However, only 50% of patients experience long-term survival after current treatment; therefore, developing novel ther...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chang, Kung-Chao, Chang, Wei-Chao, Chang, Yao, Hung, Liang-Yi, Lai, Chien-Hsien, Yeh, Yu-Min, Chou, Yu-Wei, Chen, Chung-Hsuan
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3819250/
https://ncbi.nlm.nih.gov/pubmed/24223200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079863
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados